Literature DB >> 11957788

[Current status of lung transplantation: patients, indications, techniques and outcome].

Stefan Fischer1, Martin Strüber, Axel Haverich.   

Abstract

BACKGROUND: Lung transplantation has evolved to a standard treatment modality for patients suffering from end-stage lung diseases. INDICATIONS: Accepted indications for lung transplantation include chronic obstructive pulmonary disease of the lung (COPD) and other causes of emphysema (i.e., alpha-1-antitrypsin deficiency), parenchymal diseases (i.e., idiopathic pulmonary fibrosis), genetic disorders such as cystic fibrosis, vascular diseases (i.e., primary pulmonary hypertension), chronic infectious diseases (i.e., bronchiectasis), as well as rare indications such as lymphangioleiomyomatosis or sarcoidosis. TREATMENT AND OUTCOME: This article reviews the current strategies in the treatment of lung transplant recipients, surgical techniques, limitations of and outcome after lung transplantation.

Entities:  

Mesh:

Year:  2002        PMID: 11957788     DOI: 10.1007/s00063-002-1137-9

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  2 in total

Review 1.  [Chronic obstructive lung disease].

Authors:  C Vogelmeier
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

Review 2.  Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.

Authors:  Frederick J de Serres
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.